ADMA Biologics (NASDAQ: ADMA) reported Q4 EPS of ($0.58), versus $0.50 reported last year. Revenue for the quarter came in at $524 thousand, versus $30 million reported last year.

For earnings history and earnings-related data on ADMA Biologics (ADMA) click here.